Insider Stock Trading History of Lafrance Norman D.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lafrance Norman D. since year 2005. The trader's CIK number is 1397768. At the time of this reporting, Lafrance Norman D. is the Sr. VP Clinical Dev of Molecular Insight Pharmaceuticals, Inc. . (stock ticker symbol MIPI). See this page for all insider trading activities at Molecular Insight Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Lafrance Norman D. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2009-05-28 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 6,093 3.76 22,909
2007-11-30 MIPI Molecular Insight Pharmaceuticals, Inc. Buy 2,000 8.76 17,530
2007-11-29 MIPI Molecular Insight Pharmaceuticals, Inc. Buy 2,000 8.00 16,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lafrance Norman D. (Sr. VP Clinical Dev of Molecular Insight Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.